Primary therapy with OKT3 for biopsy-proven acute renal allograft rejection.
Kamath
S
S
Department of Internal Medicine, University of Cincinnati Medical Center, OH 45267-0585, USA.
Dean
D
D
Peddi
V R
VR
Schroeder
T J
TJ
Alexander
J W
JW
Cavallo
T
T
First
M R
MR
D000328:Adult; D001707:Biopsy, Needle; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000145:classification / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000276:immunology / Q000473:pathology; D012189:Retrospective Studies; D015996:Survival Rate; D017211:Treatment Failure
D003404:Creatinine